Multi-Factorial Computational Models in Neurodiagnoses

1ï¸âƒ£ Overview

This document outlines the workflow for integrating multi-factorial computational models into Neurodiagnoses.com, leveraging multi-modal data, probabilistic disease modeling, and AI-driven progression insights for neurodegenerative diseases.

2ï¸âƒ£ Workflow Stages

Step 1: Multi-Modal Data Acquisition & Preprocessing

ğŸ”¹ Data Sources: Neuroimaging (MRI, PET, dMRI), fluid biomarkers (CSF, blood, saliva), omics (proteomics, transcriptomics, metabolomics).ğŸ”¹ Standardization: Convert all data to BIDS-compliant formats using Clinica.run.ğŸ”¹ Harmonization: Integrate cross-cohort datasets (ADNI, PPMI, UK Biobank, EBRAINS).ğŸ”¹ Preprocessing Pipelines:

Neuroimaging: FreeSurfer, ANTs, fMRIPrep for volumetric and connectivity mapping.

Fluid Biomarkers: Normalize concentrations, perform outlier detection & imputation.

Omics: Batch correction, dimensionality reduction, gene set enrichment analysis.

Output: Cleaned, harmonized dataset ready for AI model training.

Step 2: Probabilistic Disease Progression Modeling

ğŸ”¹ Event-Based Models (EBMs): Order disease-related biomarker changes along a probabilistic timeline.ğŸ”¹ Disease Progression Models (DPMs): Predict individualized disease trajectories.ğŸ”¹ Network Propagation Models: Simulate disease spread across brain connectivity networks.ğŸ”¹ Machine Learning for Risk Stratification: Implement CNNs, Random Forest, XGBoost for disease staging.

Output: Probabilistic progression scores & biomarker event timelines for each patient.

Step 3: Multi-Omics & Network-Based Disease Annotation

ğŸ”¹ Transcriptomic Vulnerability Mapping: Identify molecular pathways linked to brain atrophy regions.ğŸ”¹ Neurochemical Susceptibility Analysis: Predict which neurochemical imbalances drive pathology.ğŸ”¹ Multi-Omics Integration: Correlate omics with imaging-derived brain atrophy markers.
ğŸ”¹ Structural & Functional Network Models: Simulate how neurodegeneration propagates over time.

Output: Individualized molecularly-informed disease subtypes based on imaging-omics interactions.

Step 4: AI-Powered Clinical Decision Support & Visualization

ğŸ”¹ AI-Driven Disease Staging Dashboard:

Input: Patient neuroimaging, biomarker & omics data.

Output: Real-time probabilistic diagnosis & disease progression predictions.ğŸ”¹ 3D Visualization & Annotation:

Map biomarker abnormalities onto brain connectomes & voxel-wise regions.

Integrate tensor-based dMRI network metrics for disease propagation modeling.ğŸ”¹ Natural Language Processing (NLP):

Enable AI-powered querying via PandasAI & vision-language models.

Example: â€œShow patients with early-stage neurodegeneration affecting limbic pathways.â€

Output: Real-time AI-enhanced neurodiagnostic decision support for clinicians.

3ï¸âƒ£ Expected Impact & Next Steps

ğŸš€ AI-driven probabilistic disease diagnosis & subtyping.ğŸš€ Personalized disease progression modeling using omics-informed biomarkers.ğŸš€ Automated 3D annotation of brain imaging abnormalities.ğŸš€ NLP-powered data interaction & real-time risk assessment dashboard.

ğŸ”² Develop API for seamless integration with Neurodiagnoses.com.ğŸ”² Test model performance on real-world patient cohorts from ADNI, PPMI, EBRAINS.ğŸ”² Optimize model interpretability using SHAP/LIME for transparent AI-driven predictions.
